· Weekly signal · MRNA
Moderna Inc (MRNA) gives back 14.4% despite 36.8% four-week gain
The biotech stock’s weekly reversal complicates a broader rebound, with turnover still above recent norms.
Moderna Inc (MRNA) closed at 68.27 USD for the week ended July 10, falling -14.4% after a sharp recent advance. The move leaves the shares up 36.8% over four weeks and 27.1% over twelve weeks.
The weekly price path over 52 weeks shows the pullback landing within an active trend rather than erasing the longer rebound. Volume was elevated at 46.2 million shares versus a 13-week average of 37.6 million, while Relative Strength at 49.3 and Market Dynamics at 1.08 offer only moderate confirmation.